BRCA1 promoter hypermethylation has been implicated as one of the mechanisms of loss of gene expression and has been identified in 9–32% of unselected sporadic breast cancer [19], [25], [28]–[31]. The gene discussed is BRCA1; the disease is breast carcinoma.